Upgrade to SI Premium - Free Trial

InterCure Ltd (INCR)

5.42 +0.16 (3.04%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/17/26)
- M&A (12/31/17 *Est)

Latest Headlines

Form 6-K/A Intercure Ltd. For: Aug 27 August 27, 2026 11:39 AM - SEC Filing Form 6-K Intercure Ltd. For: Aug 26 August 26, 2026 4:06 PM - SEC Filing Form 4 Intercure Ltd. For: Jun 09 Filed by: Cohen Amos August 24, 2026 4:06 PM - SEC Filing Form 6-K Intercure Ltd. For: Aug 24 August 24, 2026 7:05 AM - SEC Filing InterCure reaches NIS 230M war damage settlement with Israel August 24, 2026 7:03 AM - StreetInsider InterCure Finalizes NIS 230 Million (~US$77 Million) Settlement for War-Related Indirect Damages August 24, 2026 7:00 AM - StreetInsider Form D Intercure Ltd. August 19, 2026 5:06 PM - SEC Filing InterCure plans 1-for-5 reverse split to meet Nasdaq price rule August 19, 2026 9:00 AM - StreetInsider InterCure Ltd. Announces 1-for-5 Reverse Share Split August 19, 2026 9:00 AM - StreetInsider Form 6-K Intercure Ltd. For: Aug 11 August 11, 2026 9:28 AM - SEC Filing Form 6-K Intercure Ltd. For: Aug 04 August 4, 2026 8:57 AM - SEC Filing Form 6-K/A Intercure Ltd. For: Jul 27 July 27, 2026 4:17 PM - SEC Filing Form 6-K Intercure Ltd. For: Jul 22 July 22, 2026 4:06 PM - SEC Filing Form 6-K Intercure Ltd. For: Jun 22 June 22, 2026 9:05 AM - SEC Filing InterCure raises NIS 22M in private placement at a share premium June 22, 2026 8:50 AM - StreetInsider InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds June 22, 2026 8:50 AM - StreetInsider Form 6-K Intercure Ltd. For: Jun 15 June 15, 2026 9:31 AM - SEC Filing InterCure completes first phase of Botanico acquisition June 15, 2026 9:25 AM - StreetInsider InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition June 15, 2026 9:25 AM - StreetInsider Full Article List